Summary of US Food and Drug Administration Chimeric Antigen Receptor (CAR) T-Cell Biologics License Application Approvals From a Statistical Perspective This review highlights strategies to integrate ...

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs) ...

Medicus Pharma (NASDAQ:MDCX) announced that it has received “study may proceed” clearance from the US Food and Drug ...

Corbus Pharmaceuticals announced results from its first-in-human dose escalation study of CRB-701, presented at the ASCO GU 2025 conference. This Phase 1 study assessed the efficacy and safety of ...

Please provide your email address to receive an email when new articles are posted on . Innovative dosing strategies are warranted to improve the well-being of individuals with metastatic breast ...

(Patients with disseminated metastatic disease from breast cancer are likely to have liver involvement in >50% of cases at some point during disease progression.) Zetagen identifies two concentrations ...

The visual nature of head and neck cancer calls for treatment strategies that will minimize toxicities related to radiation therapy. Advances in precision radiation techniques, supportive care, and ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

Ivan Buzurovic, Associate Professor of Medical Physics in Radiation Oncology Brigham and Women’s Hospital, Harvard Medical School will give a talk on “Automation, Optimization, and MRI-Only Workflows ...

Growth is driven by the rising adoption of AI-enabled dose monitoring, value-based care initiatives, and the need to balance imaging volume with patient safety. Hospitals and imaging centers are ...